Logo for Mainz Biomed NV

Mainz Biomed NV Investor Relations Material

Latest events

Logo for Mainz Biomed NV

H2 2024

1 Apr, 2025
Logo for Mainz Biomed NV

H1 2024

21 Oct, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Mainz Biomed NV

Access all reports
Mainz Biomed NV is a Germany-based molecular genetics diagnostic company focused on early detection of cancer. The company develops and commercializes in-vitro diagnostic tests, including non-invasive screening tools for colorectal cancer and other conditions. It operates in European and global markets with a focus on regulated clinical validation. The company is headquartered in Mainz, Germany, and its shares are listed on the NASDAQ.